Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:141-148
Published online before print November 23, 2005, doi: 10.1161/01.RES.0000197783.70106.4a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
98/1/141    most recent
01.RES.0000197783.70106.4av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, H.
Right arrow Articles by Field, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, H.
Right arrow Articles by Field, L. J.
Related Collections
Right arrow Structure
Right arrow Other myocardial biology
Right arrow Apoptosis
(Circulation Research. 2006;98:141.)
© 2006 American Heart Association, Inc.


Integrative Physiology

Cardiomyocyte Cell Cycle Activation Ameliorates Fibrosis in the Atrium

Hidehiro Nakajima, Hisako O. Nakajima, Klaus Dembowsky, Kishore B.S. Pasumarthi, Loren J. Field

From the Herman B Wells Center for Pediatric Research and Krannert Institute of Cardiology (H.N., H.O.N., K.B.S.P., L.J.F.), Indiana University School of Medicine, Indianapolis; and Ingenium Pharmaceuticals (K.D.), Martinsried, Germany. Current address for H.N.: Osaka-Aoyama College, Osaka, Japan. Current address for H.O.N.: Ministry of Health, Labour and Welfare, Osaka, Japan. Current address for K.B.S.P.: Dalhousie University, Halifax, Canada.

Correspondence to Loren J. Field, Herman B Wells Center for Pediatric Research, James Whitcomb Riley Hospital for Children, 1044 W Walnut St, R4-W376, Indianapolis, IN 46202-5225. E-mail ljfield{at}iupui.edu

MHC-TGFcys33ser transgenic mice have elevated levels of active transforming growth factor (TGF)-ß1 in the myocardium. Previous studies have shown that these animals develop atrial, but not ventricular, fibrosis. Here we show that atrial fibrosis was accompanied with cardiomyocyte apoptosis. Although similar levels of cardiomyocyte apoptosis were present in the right and left atria of MHC-TGFcys33ser hearts, the extent of fibrosis was more pronounced in the right atrium. Thus, additional factors influence the degree of atrial fibrosis in this model. Tritiated thymidine incorporation studies revealed cardiomyocyte cell cycle activity in left atrial cardiomyocytes, but not in right atrial cardiomyocytes. These observations suggested that cardiomyocyte cell cycle activation ameliorated the severity of atrial fibrosis. To directly test this hypothesis, MHC-TGFcys33ser mice were crossed with MHC-cycD2 mice (which have constitutive cardiomyocyte cell cycle activity in the right atrium). Mice inheriting both transgenes exhibited right atrial cardiomyocyte cell cycle activity and a concomitant reduction in the severity of right atrial fibrosis, despite the presence of a similar level of cardiomyocyte apoptosis as was observed in mice inheriting the MHC-TGFcys33ser transgene alone. These data support the notion that cardiomyocyte cell cycle induction can antagonize fibrosis in the myocardium.


Key Words: cardiomyocyte proliferation • cardiac myocyte apoptosis • heart regeneration




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
B. Burstein, X.-Y. Qi, Y.-H. Yeh, A. Calderone, and S. Nattel
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling
Cardiovasc Res, December 1, 2007; 76(3): 442 - 452.
[Abstract] [Full Text] [PDF]